Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Hu W, Xie J, Zhu T, Meng G, Wang M, Zhou Z, Guo F, Chen H, Wang Z, Wang S, Liu H, Jiang H. Serum N-Acetylneuraminic Acid Is Associated with Atrial Fibrillation and Left Atrial Enlargement. Cardiol Res Pract 2020;2020:1358098. [PMID: 32351730 DOI: 10.1155/2020/1358098] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/01/2019] [Revised: 03/12/2020] [Accepted: 03/19/2020] [Indexed: 11/29/2022] Open

For:	Hu W, Xie J, Zhu T, Meng G, Wang M, Zhou Z, Guo F, Chen H, Wang Z, Wang S, Liu H, Jiang H. Serum N-Acetylneuraminic Acid Is Associated with Atrial Fibrillation and Left Atrial Enlargement. Cardiol Res Pract 2020;2020:1358098. [PMID: 32351730 DOI: 10.1155/2020/1358098] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/01/2019] [Revised: 03/12/2020] [Accepted: 03/19/2020] [Indexed: 11/29/2022] Open

Number

Cited by Other Article(s)

Chen L, Qiu H, Chen Q, Xiang P, Lei J, Zhang J, Lu Y, Wang X, Wu S, Yu C, Ma L. N-acetylneuraminic acid modulates SQSTM1/p62 sialyation-mediated ubiquitination degradation contributing to vascular endothelium dysfunction in experimental atherosclerosis mice. IUBMB Life 2024;76:161-178. [PMID: 37818680 DOI: 10.1002/iub.2788] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2023] [Accepted: 09/12/2023] [Indexed: 10/12/2023]

Abstract

Sialic acid (SIA) has been reported to be a risk factor for atherosclerosis (AS) due to its high plasma levels in such patients. However, the effect of increasing SIA in circulation on endothelial function during AS progression remains unclear. In the present study, ApoE-/- mice and endothelial cells line (HUVEC cells) were applied to investigate the effect of SIA on AS progression and its potential molecular mechanism. In vivo, mice were injected intraperitoneally with Neu5Ac (main form of SIA) to keep high-level SIA in circulation. ORO, H&E, and Masson staining were applied to detect the plaque progression. In vitro, HUVECs were treated with Neu5Ac at different times, CCK-8, RT-PCR, western blot, and immunoprecipitation methods were used to analyze its effects on endothelial function and the potential involved mechanism. Results from the present study showed that high plasma levels of Neu5Ac in ApoE-/- mice could aggravate the plaque areas as well as increase necrotic core areas and collagen fiber contents. Remarkably, Neu5Ac levels in circulation displayed a positive correlation with AS plaque areas. Furthermore, results from HUVECs showed that Neu5Ac inhibited cells viability in a time/dose-dependent manner, by then induced the activation of inflammation makers such as ICAM-1 and IL-1β. Mechanism study showed that the activation of excessive autophagy medicated by SQSTM1/p62 displayed an important role in endothelium inflammatory injury. Neu5Ac could modify SQSTM1/p62 as a sialylation protein, and then increase its level with ubiquitin binding, further inducing ubiquitination degradation and being involved in the excessive autophagy pathway. Inhibition of sialylation by P-3Fax-Neu5Ac, a sialyltransferase inhibitor, reduced the binding of SQSTM1/p62 to ubiquitin. Together, these findings indicated that Neu5Ac increased SQSTM1/p62-ubiquitin binding through sialylation modification, thereby inducing excessive autophagy and subsequent endothelial injury. Inhibition of SQSTM1/p62 sialylation might be a potential strategy for preventing such disease with high levels of Neu5Ac in circulation.

Collapse

Talaei F, Banga A, Pursell A, Gage A, Pallipamu N, Seri AR, Adhikari R, Kashyap R, Surani S. New-onset atrial fibrillation among COVID-19 patients: A narrative review. World J Crit Care Med 2023;12:236-247. [PMID: 38188450 PMCID: PMC10768419 DOI: 10.5492/wjccm.v12.i5.236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/30/2023] [Revised: 08/20/2023] [Accepted: 09/11/2023] [Indexed: 12/07/2023] Open

Ping Z, Zhang XL, Wang ZW, Cao XB. The effect of long-term moderate exercise on myocardial metabolome in rats. CHINESE J PHYSIOL 2023;66:558-566. [PMID: 38149568 DOI: 10.4103/cjop.cjop-d-23-00126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2023] Open

Abstract

Regular moderate physical exercise is beneficial for the cardiovascular system. Our prior study has demonstrated a long-term moderate exercise (4-week of 60-min 74.0% V̇O2max treadmill running) is optimal in protecting from exhaustive exercise-induced cardiac ischemic injury. This study is aimed to investigate the effect of long-term moderate exercise on myocardial metabolome in rats. Thirteen male Sprague-Dawley rats were randomly assigned into the control group (C) and the long-term moderate exercise group (E). The targeted metabolomics of the myocardium was analyzed by ultra-performance liquid chromatography coupled to tandem mass spectrometry (UPLC-MS/MS) system. Results showed that the metabolites categories of bile acids (BAs), fatty acids (FAs), and phenylpropanoic acids were significantly decreased. The biosynthesis of unsaturated FAs pathway was significantly downregulated. The altered metabolites in the E Group included decreased FAs (pentadecanoic acid, 10Z-heptadecenoic acid, dihomo-gamma-linolenic acid, docosahexaenoic acid, docosapentaenoic acid, and 10Z-nonadecenoic acid), decreased BAs (chenodeoxycholic acid and beta-muricholic acid), decreased organic acids (glycolic acid and 2-hydroxyglutaric acid), decreased carbohydrate (N-acetylneuraminic acid, Neu5Ac), decreased amino acids (α-aminobutyric acid and norvaline), decreased phenylpropanoic acids (hydroxyphenyllactic acid), and benzoic acids (4-hydroxybenzoic acid and phthalic acid). The results indicated that long-term moderate exercise has promoted lipids utilization in myocardium while exerted little influence on carbohydrate metabolism and diminished many detrimental metabolites. Notably, decrease of myocardial carbohydrate Neu5Ac after long-term moderate exercise might predict a prospective metabolomics biomarker for cardioprotection. This research has displayed the effect of long-term moderate exercise on myocardial metabolomic profiling in rats and indicated some promising metabolites which can be applied for exercise benefits in future.

Collapse

Hashimoto H, Hiyoshi Y, Kabuki T, Sasaki H, Toda M. Prognostic value of ECG monitor findings in COVID-19. Open Heart 2023;10:e002404. [PMID: 37963684 PMCID: PMC10649884 DOI: 10.1136/openhrt-2023-002404] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/29/2023] [Accepted: 10/31/2023] [Indexed: 11/16/2023] Open

Abstract

AIMS

COVID-19 can cause severe illness and multiorgan dysfunction. Acute myocardial damage has been detected in a significant portion of patients with COVID-19; therefore, several studies have reported that electrocardiographic findings could be used to evaluate the severalty of COVID-19. However, performing standard ECG for each patient hospitalised with COVID-19 can increase the level of exposure to COVID-19 among medical staff. Therefore, this study aimed to investigate the prognostic value of continuous electrocardiographic monitor findings in patients with COVID-19.

METHODS

Among 1612 consecutive patients with COVID-19 who were admitted to our hospital between August 2021 and May 2022, we identified 96 (76±4 years) patients who underwent electrocardiographic monitor during hospitalisation. All electrocardiographic monitors were analysed by two independent cardiologists blinded to the clinical data of the patients. The endpoint was defined as the occurrence of all-cause mortality related to COVID-19. The event data were retrospectively gathered from the patients' medical records. A multivariate Cox model was used to assess whether these electrocardiographic monitor findings and clinical data were associated with in-hospital mortality.

RESULTS

During a mean hospitalisation period of 22.8±3.2 days, in-hospital mortality occurred in 17 (18%) patients. Atrial fibrillation (HR: 3.95, 95% CI: 1.39 to 11.21) and lung disease complications (HR: 2.91, 95% CI: 1.06 to 7.98) were significant prognostic factors for death in multivariate analysis. Compared with the non-complicated lung disease and non-atrial fibrillation group, the risk of mortality was significantly higher in the lung disease complication and atrial fibrillation group in the multivariate Cox proportional model (HR: 8.37, 95% CI: 1.69 to 41.30, p=0.009).

CONCLUSIONS

The simple method of ECG monitor could adequately detect atrial fibrillation. This study demonstrated that atrial fibrillation complicated with lung disease, could have potential prognostic value among patients with COVID-19.

Collapse

Liu C, Ge P, Zeng C, Yu X, Zhai Y, Liu W, He Q, Li J, Liu X, Wang J, Ye X, Zhang Q, Wang R, Zhang Y, Zhao J, Zhang D. Correlation of Serum N-Acetylneuraminic Acid with the Risk of Moyamoya Disease. Brain Sci 2023;13:913. [PMID: 37371391 PMCID: PMC10296217 DOI: 10.3390/brainsci13060913] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2023] [Revised: 05/28/2023] [Accepted: 06/02/2023] [Indexed: 06/29/2023] Open

Affiliation(s)

Chenglong Liu Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 119 South Fourth Ring West Road, Fengtai District, Beijing 100070, China; (C.L.); (P.G.); (C.Z.); (X.Y.); (Y.Z.); (W.L.); (Q.H.); (J.L.); (X.L.); (J.W.); (X.Y.); (Q.Z.); (R.W.); (Y.Z.) China National Clinical Research Center for Neurological Diseases, Beijing 100070, China Center of Stroke, Beijing Institute for Brain Disorders, Beijing 100070, China Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing 100070, China Beijing Translational Engineering Center for 3D Printer in Clinical Neuroscience, Beijing 100070, China
Peicong Ge Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 119 South Fourth Ring West Road, Fengtai District, Beijing 100070, China; (C.L.); (P.G.); (C.Z.); (X.Y.); (Y.Z.); (W.L.); (Q.H.); (J.L.); (X.L.); (J.W.); (X.Y.); (Q.Z.); (R.W.); (Y.Z.) China National Clinical Research Center for Neurological Diseases, Beijing 100070, China Center of Stroke, Beijing Institute for Brain Disorders, Beijing 100070, China Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing 100070, China Beijing Translational Engineering Center for 3D Printer in Clinical Neuroscience, Beijing 100070, China
Chaofan Zeng Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 119 South Fourth Ring West Road, Fengtai District, Beijing 100070, China; (C.L.); (P.G.); (C.Z.); (X.Y.); (Y.Z.); (W.L.); (Q.H.); (J.L.); (X.L.); (J.W.); (X.Y.); (Q.Z.); (R.W.); (Y.Z.) China National Clinical Research Center for Neurological Diseases, Beijing 100070, China Center of Stroke, Beijing Institute for Brain Disorders, Beijing 100070, China Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing 100070, China Beijing Translational Engineering Center for 3D Printer in Clinical Neuroscience, Beijing 100070, China
Xiaofan Yu Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 119 South Fourth Ring West Road, Fengtai District, Beijing 100070, China; (C.L.); (P.G.); (C.Z.); (X.Y.); (Y.Z.); (W.L.); (Q.H.); (J.L.); (X.L.); (J.W.); (X.Y.); (Q.Z.); (R.W.); (Y.Z.) China National Clinical Research Center for Neurological Diseases, Beijing 100070, China Center of Stroke, Beijing Institute for Brain Disorders, Beijing 100070, China Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing 100070, China Beijing Translational Engineering Center for 3D Printer in Clinical Neuroscience, Beijing 100070, China
Yuanren Zhai Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 119 South Fourth Ring West Road, Fengtai District, Beijing 100070, China; (C.L.); (P.G.); (C.Z.); (X.Y.); (Y.Z.); (W.L.); (Q.H.); (J.L.); (X.L.); (J.W.); (X.Y.); (Q.Z.); (R.W.); (Y.Z.) China National Clinical Research Center for Neurological Diseases, Beijing 100070, China Center of Stroke, Beijing Institute for Brain Disorders, Beijing 100070, China Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing 100070, China Beijing Translational Engineering Center for 3D Printer in Clinical Neuroscience, Beijing 100070, China
Wei Liu Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 119 South Fourth Ring West Road, Fengtai District, Beijing 100070, China; (C.L.); (P.G.); (C.Z.); (X.Y.); (Y.Z.); (W.L.); (Q.H.); (J.L.); (X.L.); (J.W.); (X.Y.); (Q.Z.); (R.W.); (Y.Z.) China National Clinical Research Center for Neurological Diseases, Beijing 100070, China Center of Stroke, Beijing Institute for Brain Disorders, Beijing 100070, China Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing 100070, China Beijing Translational Engineering Center for 3D Printer in Clinical Neuroscience, Beijing 100070, China
Qiheng He Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 119 South Fourth Ring West Road, Fengtai District, Beijing 100070, China; (C.L.); (P.G.); (C.Z.); (X.Y.); (Y.Z.); (W.L.); (Q.H.); (J.L.); (X.L.); (J.W.); (X.Y.); (Q.Z.); (R.W.); (Y.Z.) China National Clinical Research Center for Neurological Diseases, Beijing 100070, China Center of Stroke, Beijing Institute for Brain Disorders, Beijing 100070, China Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing 100070, China Beijing Translational Engineering Center for 3D Printer in Clinical Neuroscience, Beijing 100070, China
Junsheng Li Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 119 South Fourth Ring West Road, Fengtai District, Beijing 100070, China; (C.L.); (P.G.); (C.Z.); (X.Y.); (Y.Z.); (W.L.); (Q.H.); (J.L.); (X.L.); (J.W.); (X.Y.); (Q.Z.); (R.W.); (Y.Z.) China National Clinical Research Center for Neurological Diseases, Beijing 100070, China Center of Stroke, Beijing Institute for Brain Disorders, Beijing 100070, China Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing 100070, China Beijing Translational Engineering Center for 3D Printer in Clinical Neuroscience, Beijing 100070, China
Xingju Liu Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 119 South Fourth Ring West Road, Fengtai District, Beijing 100070, China; (C.L.); (P.G.); (C.Z.); (X.Y.); (Y.Z.); (W.L.); (Q.H.); (J.L.); (X.L.); (J.W.); (X.Y.); (Q.Z.); (R.W.); (Y.Z.) China National Clinical Research Center for Neurological Diseases, Beijing 100070, China Center of Stroke, Beijing Institute for Brain Disorders, Beijing 100070, China Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing 100070, China Beijing Translational Engineering Center for 3D Printer in Clinical Neuroscience, Beijing 100070, China
Jia Wang Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 119 South Fourth Ring West Road, Fengtai District, Beijing 100070, China; (C.L.); (P.G.); (C.Z.); (X.Y.); (Y.Z.); (W.L.); (Q.H.); (J.L.); (X.L.); (J.W.); (X.Y.); (Q.Z.); (R.W.); (Y.Z.) China National Clinical Research Center for Neurological Diseases, Beijing 100070, China Center of Stroke, Beijing Institute for Brain Disorders, Beijing 100070, China Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing 100070, China Beijing Translational Engineering Center for 3D Printer in Clinical Neuroscience, Beijing 100070, China
Xun Ye Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 119 South Fourth Ring West Road, Fengtai District, Beijing 100070, China; (C.L.); (P.G.); (C.Z.); (X.Y.); (Y.Z.); (W.L.); (Q.H.); (J.L.); (X.L.); (J.W.); (X.Y.); (Q.Z.); (R.W.); (Y.Z.) China National Clinical Research Center for Neurological Diseases, Beijing 100070, China Center of Stroke, Beijing Institute for Brain Disorders, Beijing 100070, China Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing 100070, China Beijing Translational Engineering Center for 3D Printer in Clinical Neuroscience, Beijing 100070, China
Qian Zhang Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 119 South Fourth Ring West Road, Fengtai District, Beijing 100070, China; (C.L.); (P.G.); (C.Z.); (X.Y.); (Y.Z.); (W.L.); (Q.H.); (J.L.); (X.L.); (J.W.); (X.Y.); (Q.Z.); (R.W.); (Y.Z.) China National Clinical Research Center for Neurological Diseases, Beijing 100070, China Center of Stroke, Beijing Institute for Brain Disorders, Beijing 100070, China Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing 100070, China Beijing Translational Engineering Center for 3D Printer in Clinical Neuroscience, Beijing 100070, China
Rong Wang Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 119 South Fourth Ring West Road, Fengtai District, Beijing 100070, China; (C.L.); (P.G.); (C.Z.); (X.Y.); (Y.Z.); (W.L.); (Q.H.); (J.L.); (X.L.); (J.W.); (X.Y.); (Q.Z.); (R.W.); (Y.Z.) China National Clinical Research Center for Neurological Diseases, Beijing 100070, China Center of Stroke, Beijing Institute for Brain Disorders, Beijing 100070, China Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing 100070, China Beijing Translational Engineering Center for 3D Printer in Clinical Neuroscience, Beijing 100070, China
Yan Zhang Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 119 South Fourth Ring West Road, Fengtai District, Beijing 100070, China; (C.L.); (P.G.); (C.Z.); (X.Y.); (Y.Z.); (W.L.); (Q.H.); (J.L.); (X.L.); (J.W.); (X.Y.); (Q.Z.); (R.W.); (Y.Z.) China National Clinical Research Center for Neurological Diseases, Beijing 100070, China Center of Stroke, Beijing Institute for Brain Disorders, Beijing 100070, China Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing 100070, China Beijing Translational Engineering Center for 3D Printer in Clinical Neuroscience, Beijing 100070, China
Jizong Zhao Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 119 South Fourth Ring West Road, Fengtai District, Beijing 100070, China; (C.L.); (P.G.); (C.Z.); (X.Y.); (Y.Z.); (W.L.); (Q.H.); (J.L.); (X.L.); (J.W.); (X.Y.); (Q.Z.); (R.W.); (Y.Z.) China National Clinical Research Center for Neurological Diseases, Beijing 100070, China Center of Stroke, Beijing Institute for Brain Disorders, Beijing 100070, China Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing 100070, China Beijing Translational Engineering Center for 3D Printer in Clinical Neuroscience, Beijing 100070, China
Dong Zhang Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 119 South Fourth Ring West Road, Fengtai District, Beijing 100070, China; (C.L.); (P.G.); (C.Z.); (X.Y.); (Y.Z.); (W.L.); (Q.H.); (J.L.); (X.L.); (J.W.); (X.Y.); (Q.Z.); (R.W.); (Y.Z.) China National Clinical Research Center for Neurological Diseases, Beijing 100070, China Center of Stroke, Beijing Institute for Brain Disorders, Beijing 100070, China Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing 100070, China Beijing Translational Engineering Center for 3D Printer in Clinical Neuroscience, Beijing 100070, China Department of Neurosurgery, Beijing Hospital, Beijing 100730, China

Collapse

Donniacuo M, De Angelis A, Rafaniello C, Cianflone E, Paolisso P, Torella D, Sibilio G, Paolisso G, Castaldo G, Urbanek K, Rossi F, Berrino L, Cappetta D. COVID-19 and atrial fibrillation: Intercepting lines. Front Cardiovasc Med 2023;10:1093053. [PMID: 36755799 PMCID: PMC9899905 DOI: 10.3389/fcvm.2023.1093053] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2022] [Accepted: 01/09/2023] [Indexed: 01/24/2023] Open

Li MN, Bao BW, Si-Yu D, Chun-Fei J, Xiao-Jun S, Da-Sheng G, Qin G, Hong-Ju W. Correlation between plasma glutathione peroxidase 4 and N-acetylneuraminic acid levels with clinical risk stratification and prognosis of patients with acute coronary syndrome. Saudi Med J 2022;43:1103-1110. [PMID: 36261209 PMCID: PMC9994492 DOI: 10.15537/smj.2022.43.10.20220444] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2022] [Accepted: 09/19/2022] [Indexed: 06/16/2023] Open

Affiliation(s)

Miao-Nan Li From the Department of Cardiovascular Disease (Li, Bao, Ding, Ji, Shi, D-S. Gao, Q. Gao, Wang), The First Affiliated Hospital of Bengbu Medical College, and from the Department of Physiology (Q. Gao), Key Laboratory of Cardiovascular and Cerebrovascular Diseases, Bengbu Medical College, Bengbu, China.
Bing-Wei Bao From the Department of Cardiovascular Disease (Li, Bao, Ding, Ji, Shi, D-S. Gao, Q. Gao, Wang), The First Affiliated Hospital of Bengbu Medical College, and from the Department of Physiology (Q. Gao), Key Laboratory of Cardiovascular and Cerebrovascular Diseases, Bengbu Medical College, Bengbu, China.
Ding Si-Yu From the Department of Cardiovascular Disease (Li, Bao, Ding, Ji, Shi, D-S. Gao, Q. Gao, Wang), The First Affiliated Hospital of Bengbu Medical College, and from the Department of Physiology (Q. Gao), Key Laboratory of Cardiovascular and Cerebrovascular Diseases, Bengbu Medical College, Bengbu, China.
Ji Chun-Fei From the Department of Cardiovascular Disease (Li, Bao, Ding, Ji, Shi, D-S. Gao, Q. Gao, Wang), The First Affiliated Hospital of Bengbu Medical College, and from the Department of Physiology (Q. Gao), Key Laboratory of Cardiovascular and Cerebrovascular Diseases, Bengbu Medical College, Bengbu, China.
Shi Xiao-Jun From the Department of Cardiovascular Disease (Li, Bao, Ding, Ji, Shi, D-S. Gao, Q. Gao, Wang), The First Affiliated Hospital of Bengbu Medical College, and from the Department of Physiology (Q. Gao), Key Laboratory of Cardiovascular and Cerebrovascular Diseases, Bengbu Medical College, Bengbu, China.
Gao Da-Sheng From the Department of Cardiovascular Disease (Li, Bao, Ding, Ji, Shi, D-S. Gao, Q. Gao, Wang), The First Affiliated Hospital of Bengbu Medical College, and from the Department of Physiology (Q. Gao), Key Laboratory of Cardiovascular and Cerebrovascular Diseases, Bengbu Medical College, Bengbu, China.
Gao Qin From the Department of Cardiovascular Disease (Li, Bao, Ding, Ji, Shi, D-S. Gao, Q. Gao, Wang), The First Affiliated Hospital of Bengbu Medical College, and from the Department of Physiology (Q. Gao), Key Laboratory of Cardiovascular and Cerebrovascular Diseases, Bengbu Medical College, Bengbu, China.
Wang Hong-Ju From the Department of Cardiovascular Disease (Li, Bao, Ding, Ji, Shi, D-S. Gao, Q. Gao, Wang), The First Affiliated Hospital of Bengbu Medical College, and from the Department of Physiology (Q. Gao), Key Laboratory of Cardiovascular and Cerebrovascular Diseases, Bengbu Medical College, Bengbu, China.

Collapse

Dougherty BV, Rawls KD, Kolling GL, Vinnakota KC, Wallqvist A, Papin JA. Identifying functional metabolic shifts in heart failure with the integration of omics data and a heart-specific, genome-scale model. Cell Rep 2021;34:108836. [PMID: 33691118 DOI: 10.1016/j.celrep.2021.108836] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2020] [Revised: 01/07/2021] [Accepted: 02/17/2021] [Indexed: 11/28/2022] Open

Gawałko M, Kapłon-Cieślicka A, Hohl M, Dobrev D, Linz D. COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications. IJC HEART & VASCULATURE 2020;30:100631. [PMID: 32904969 PMCID: PMC7462635 DOI: 10.1016/j.ijcha.2020.100631] [Citation(s) in RCA: 78] [Impact Index Per Article: 15.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2020] [Revised: 08/14/2020] [Accepted: 08/25/2020] [Indexed: 01/08/2023]